Scholarly Index
Alberto Ocaña
Universidad San Pablo CEU; 20,585 total citations; 401 total publications; best world rank #279
Universidad San Pablo CEU
20,585Total citations
401Total publications
63H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HER2/EGFR in Cancer Research | Lifetime | 312 | ES 10 | 98.65 |
| Peptidase Inhibition and Analysis | Lifetime | 803 | ES 24 | 97.45 |
| Protein Degradation and Inhibitors | Lifetime | 350 | ES 15 | 97.26 |
| Economic and Financial Impacts of Cancer | Lifetime | 374 | ES 2 | 96.02 |
| Advanced Breast Cancer Therapies | Lifetime | 511 | ES 15 | 96.01 |
| Statistical Methods in Clinical Trials | Lifetime | 985 | ES 3 | 91.18 |
| 14-3-3 protein interactions | Lifetime | 928 | ES 19 | 76.65 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 279 | ES 16 | 95.24 |
| Peptidase Inhibition and Analysis | 2021-2025 | 392 | ES 19 | 92.75 |
| HER2/EGFR in Cancer Research | 2021-2025 | 350 | ES 19 | 94.17 |
| Protein Degradation and Inhibitors | 2021-2025 | 749 | ES 24 | 86.97 |